Revisiting the tumorigenesis timeline with a data-driven generative model
Open Access
- 14 January 2020
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (2), 857-864
- https://doi.org/10.1073/pnas.1914589117
Abstract
Cancer is driven by the sequential accumulation of genetic and epigenetic changes in oncogenes and tumor suppressor genes. The timing of these events is not well understood. Moreover, it is currently unknown why the same driver gene change appears as an early event in some cancer types and as a later event, or not at all, in others. These questions have become even more topical with the recent progress brought by genome-wide sequencing studies of cancer. Focusing on mutational events, we provide a mathematical model of the full process of tumor evolution that includes different types of fitness advantages for driver genes and carrying capacity considerations. The model is able to recapitulate a substantial proportion of the observed cancer incidence in several cancer types (colorectal, pancreatic, and leukemia) and inherited conditions (Lynch and familial adenomatous polyposis), by changing only 2 tissue-specific parameters: the number of stem cells in a tissue and its cell division frequency. The model sheds light on the evolutionary dynamics of cancer by suggesting a generalized early onset of tumorigenesis followed by slow mutational waves, in contrast to previous conclusions. Formulas and estimates are provided for the fitness increases induced by driver mutations, often much larger than previously described, and highly tissue dependent. Our results suggest a mechanistic explanation for why the selective fitness advantage introduced by specific driver genes is tissue dependent.Keywords
Funding Information
- John Templeton Foundation (N/A)
- HHS | NIH | National Cancer Institute (R01-CA200859)
- The Maryland Cigarette Restitution Fund (N/A)
- Lustgarten Foundation (N/A)
- Virginia and D.K. Ludwig Fund for Cancer Research (N/A)
- The Sol Goldman Pancreatic Cancer Research Center (N/A)
- NIH (R37-CA43460)
- NIH (RO1-CA57345)
- NIH (RO1-CA179991)
- NIH (P50-CA62924)
- NIH (P30-CA006973)
This publication has 42 references indexed in Scilit:
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Predicting clonal self-renewal and extinction of hematopoietic stem cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Accumulation of driver and passenger mutations during tumor progressionProceedings of the National Academy of Sciences, 2010
- Role of symmetric and asymmetric division of stem cells in developing drug resistanceProceedings of the National Academy of Sciences of the United States of America, 2010
- Hereditary and Familial Colon CancerGastroenterology, 2010
- Calculation of Risk of Colorectal and Endometrial Cancer Among Patients With Lynch SyndromeGastroenterology, 2009
- The cancer genomeNature, 2009
- Comparative lesion sequencing provides insights into tumor evolutionProceedings of the National Academy of Sciences, 2008
- Molecular genetics of pancreatic intraepithelial neoplasiaJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Cell production rates in human tissues and tumours and their significance. Part II: clinical dataEuropean Journal of Surgical Oncology, 2000